Active
Small Business
Overview
- Legal name
- INBIOS INTERNATIONAL INC
- Registered location
- SEATTLE, WA, USA
- Website
- Company website ↗
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Latest award activity
- Aug 20, 2026
Read company summary
INBIOS INTERNATIONAL INC is associated with UEI CNJNQ1GMSN55 and CAGE 3KJL6 in public federal records. AcornBids currently links 6 prime awards totaling $49.7M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing; Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists SEATTLE, WA, USA.
At a glance
Lifetime prime obligations$49.7M
Prime awards6
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 8, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- INBIOS INTERNATIONAL INC
- UEI
- CNJNQ1GMSN55
- CAGE
- 3KJL6
- Registered address
- 307 WESTLAKE AVE N STE 300, SEATTLE, WA, 98109, USA
- Registration status
- Active
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- SAM activation
- Dec 11, 2025
- Initial registration
- Oct 16, 2003
- Entity start
- Oct 19, 1996
- SAM updated
- Dec 11, 2025
- Registration expires
- Dec 10, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- WA, USA
Research brief
Source facts
- Loaded prime-award records link 6 awards and $49,707,827 in reported obligations to this legal entity. Source
- Recorded awards include 541711 (NAICS 541711); this classification is not proof of every company capability. Source
- An example award describes: IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$2.9M
Prime contracts
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 6 of 6 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HHSO100201700029CIGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX | Department of Health and Human Services | $4.0M | Sep 26, 2017 | Sep 30, 2027 |
| 75D30126P20991INBIOS REAGENTS KITS | Department of Health and Human Services | $62.3K | Apr 20, 2026 | Sep 19, 2026 |
| 75D30123P17663INBIOS SUPPLIES & REAGENTS | Department of Health and Human Services | $18.8K | Aug 24, 2023 | Sep 28, 2023 |
| W81XWH20F0253COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION | Department of Defense | $24.5M | Jun 15, 2020 | May 31, 2025 |
| 75N91024C00078TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD | Department of Health and Human Services | $399.9K | Sep 16, 2024 | Sep 15, 2025 |
| 75A50223C00041OVER THE COUNTER (OTC) COVID-19 TESTS | Department of Health and Human Services | $20.7M | Sep 20, 2023 | Mar 19, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 11, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Oct 16, 2003 |
| Entity start | Oct 19, 1996 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ESTELA RAYCHAUDHURI | Government business | Contact method not published | SAM registration | Not available |
| SYAMAL RAYCHAUDHURI | Alternate government business | Contact method not published | SAM registration | Not available |
| ESTELA RAYCHAUDHURI | Electronic business | Contact method not published | SAM registration | Not available |
| SYAMAL RAYCHAUDHURI | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
10 awards
5 awards
21 awards
3 awards
About INBIOS INTERNATIONAL INC
What products and services appear in its federal awards?
Recorded award industries: 541711; 325413 — In-Vitro Diagnostic Substance Manufacturing; 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AJ53 — LIFE SCIENCES - ADVANCED DEVELOPMENT; 6650 — Optical Instruments, Test Equipment, Components and Accessories; AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH.
Examples from recent award records:
- IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX
- INBIOS REAGENTS KITS
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
307 WESTLAKE AVE N STE 300, SEATTLE, Washington 98109, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325413 — In-Vitro Diagnostic Substance Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services; Department of Defense.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit